JESSICA MCGRATH: Open Payments
NPI 1336348028 · FRACKVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 22 payments from 10 companies in 2025. Trend: 2023 $638 · 2024 $368 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $87 |
| Exeltis, USA Inc. | 4 | $70 |
| MILLICENT US INC | 4 | $66 |
| ABBVIE INC. | 2 | $36 |
| Amgen Inc. | 2 | $27 |
| Acella Pharmaceuticals, LLC | 1 | $21 |
| Olympus America Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $14 |
Products named: SLYND, INTRAROSA, GEMTESA, MYFEMBREE, LILETTA, EVENITY, NP Thyroid 60, Olympus.
Industry payments across PA — which companies pay providers there.
